The Himalayan Journal of Tuberculosis and Respiratory Diseases, under the guidance of Dr. Amit Sachdeva and supported by iARCON, stands as a premier source of scientific insights and clinical advancements in the realm of tuberculosis (TB) and respiratory diseases. Initially conceived to address the unique healthcare challenges of the Himalayan region, the journal has evolved into a global platform, dedicated to advancing the prevention, diagnosis, and treatment of TB and respiratory conditions worldwide.
Our journal is dedicated to publishing high-quality, peer-reviewed research, review articles, and clinical case studies focusing on tuberculosis and respiratory diseases. It serves as a vital platform for disseminating significant findings in pulmonary health, including innovative treatment modalities, diagnostic advancements, epidemiological studies, and public health interventions. With a strong emphasis on research that offers actionable insights into combating TB and managing respiratory ailments, our journal plays a crucial role in shaping clinical practices and enhancing patient care across diverse healthcare settings.
Operating under an open-access model, the Himalayan Journal of Tuberculosis and Respiratory Diseases ensures universal access to its valuable content for researchers, healthcare professionals, and the public worldwide. By embracing this approach, we facilitate the widespread dissemination of knowledge, fostering collaborative efforts to tackle the challenges posed by TB and respiratory diseases and ultimately contributing to improved health outcomes on a global scale.